Marlowe PLC Appointment of Joint Broker (6767V)

TIDMMRL

RNS Number : 6767V

Marlowe PLC

10 April 2019

Marlowe plc

("Marlowe" or the "Company")

Appointment of Joint Broker

Marlowe, the specialist services group focused on developing companies which assure safety and regulatory compliance, announces the appointment of Berenberg as the Company's joint corporate broker to work alongside its existing corporate broker and Nominated Adviser, Cenkos, with immediate effect.

END

For further information:

 
 Marlow plc                                 www.marloweplc.com 
  Alex Dacre, Chief Executive                Tel: +44 (0) 203 841 6194 
  Mark Adams, Group Finance Director         IR@marloweplc.com 
 Cenkos Securities plc (Nominated Adviser   Tel: +44 (0)20 7397 8900 
  and Joint Broker) 
  Nicholas Wells 
  Harry Hargreaves 
 Berenberg (Joint Broker)                   Tel: +44 (0) 20 3207 7800 
  Ben Wright 
  Mark Whitmore 
 FTI Consulting                             Tel: +44 (0)20 3727 1340 
  Nick Hasell 
  Alex Le May

About Marlowe

Marlowe is a UK leader in specialist services which assure the safety and regulatory compliance of commercial properties, whilst managing risk for businesses across the country. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated inspection, testing and compliance services. It is focused on health & safety, fire safety, security, water safety, water treatment, air quality and environmental services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides services to over 10% of Britain's commercial properties and is increasingly attractive to customers who require a single outsourced, nationwide, provider of a comprehensive range of regulated safety services. Our customers can be found in most office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

For further information, please visit www.marloweplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

APPEAKLNEESNEFF

(END) Dow Jones Newswires

April 10, 2019 02:01 ET (06:01 GMT)

Marlowe (LSE:MRL)
Historical Stock Chart
From Apr 2024 to May 2024